Global Isovaleric Acidemia Treatment Supply, Demand and Key Producers, 2023-2029
This report studies the global Isovaleric Acidemia Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Isovaleric Acidemia Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Isovaleric Acidemia Treatment that contribute to its increasing demand across many markets.
The global Isovaleric Acidemia Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Isovaleric Acidemia Treatment total production and demand, 2018-2029, (K Units)
Global Isovaleric Acidemia Treatment total production value, 2018-2029, (USD Million)
Global Isovaleric Acidemia Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Isovaleric Acidemia Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Isovaleric Acidemia Treatment domestic production, consumption, key domestic manufacturers and share
Global Isovaleric Acidemia Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Isovaleric Acidemia Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Isovaleric Acidemia Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Isovaleric Acidemia Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Replimune Group Inc., Transgene SA, Oncolys BioPharma, Targovax, Lokon Pharma, Vyriad, TILT Biotherapeutics and VCNBiosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Isovaleric Acidemia Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Isovaleric Acidemia Treatment Market, By Region:
1. How big is the global Isovaleric Acidemia Treatment market?
2. What is the demand of the global Isovaleric Acidemia Treatment market?
3. What is the year over year growth of the global Isovaleric Acidemia Treatment market?
4. What is the production and production value of the global Isovaleric Acidemia Treatment market?
5. Who are the key producers in the global Isovaleric Acidemia Treatment market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Isovaleric Acidemia Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Isovaleric Acidemia Treatment that contribute to its increasing demand across many markets.
The global Isovaleric Acidemia Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Isovaleric Acidemia Treatment total production and demand, 2018-2029, (K Units)
Global Isovaleric Acidemia Treatment total production value, 2018-2029, (USD Million)
Global Isovaleric Acidemia Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Isovaleric Acidemia Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Isovaleric Acidemia Treatment domestic production, consumption, key domestic manufacturers and share
Global Isovaleric Acidemia Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Isovaleric Acidemia Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Isovaleric Acidemia Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Isovaleric Acidemia Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Replimune Group Inc., Transgene SA, Oncolys BioPharma, Targovax, Lokon Pharma, Vyriad, TILT Biotherapeutics and VCNBiosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Isovaleric Acidemia Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Isovaleric Acidemia Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- L-Carnitine Supplements
- Glycine Supplements
- Others
- Hospital
- Personal
- Other
- Amgen
- Replimune Group Inc.
- Transgene SA
- Oncolys BioPharma
- Targovax
- Lokon Pharma
- Vyriad
- TILT Biotherapeutics
- VCNBiosciences
- DNAtrix
1. How big is the global Isovaleric Acidemia Treatment market?
2. What is the demand of the global Isovaleric Acidemia Treatment market?
3. What is the year over year growth of the global Isovaleric Acidemia Treatment market?
4. What is the production and production value of the global Isovaleric Acidemia Treatment market?
5. Who are the key producers in the global Isovaleric Acidemia Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Isovaleric Acidemia Treatment Introduction
1.2 World Isovaleric Acidemia Treatment Supply & Forecast
1.2.1 World Isovaleric Acidemia Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Isovaleric Acidemia Treatment Production (2018-2029)
1.2.3 World Isovaleric Acidemia Treatment Pricing Trends (2018-2029)
1.3 World Isovaleric Acidemia Treatment Production by Region (Based on Production Site)
1.3.1 World Isovaleric Acidemia Treatment Production Value by Region (2018-2029)
1.3.2 World Isovaleric Acidemia Treatment Production by Region (2018-2029)
1.3.3 World Isovaleric Acidemia Treatment Average Price by Region (2018-2029)
1.3.4 North America Isovaleric Acidemia Treatment Production (2018-2029)
1.3.5 Europe Isovaleric Acidemia Treatment Production (2018-2029)
1.3.6 China Isovaleric Acidemia Treatment Production (2018-2029)
1.3.7 Japan Isovaleric Acidemia Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Isovaleric Acidemia Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Isovaleric Acidemia Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Isovaleric Acidemia Treatment Demand (2018-2029)
2.2 World Isovaleric Acidemia Treatment Consumption by Region
2.2.1 World Isovaleric Acidemia Treatment Consumption by Region (2018-2023)
2.2.2 World Isovaleric Acidemia Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Isovaleric Acidemia Treatment Consumption (2018-2029)
2.4 China Isovaleric Acidemia Treatment Consumption (2018-2029)
2.5 Europe Isovaleric Acidemia Treatment Consumption (2018-2029)
2.6 Japan Isovaleric Acidemia Treatment Consumption (2018-2029)
2.7 South Korea Isovaleric Acidemia Treatment Consumption (2018-2029)
2.8 ASEAN Isovaleric Acidemia Treatment Consumption (2018-2029)
2.9 India Isovaleric Acidemia Treatment Consumption (2018-2029)
3 WORLD ISOVALERIC ACIDEMIA TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Isovaleric Acidemia Treatment Production Value by Manufacturer (2018-2023)
3.2 World Isovaleric Acidemia Treatment Production by Manufacturer (2018-2023)
3.3 World Isovaleric Acidemia Treatment Average Price by Manufacturer (2018-2023)
3.4 Isovaleric Acidemia Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Isovaleric Acidemia Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Isovaleric Acidemia Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Isovaleric Acidemia Treatment in 2022
3.6 Isovaleric Acidemia Treatment Market: Overall Company Footprint Analysis
3.6.1 Isovaleric Acidemia Treatment Market: Region Footprint
3.6.2 Isovaleric Acidemia Treatment Market: Company Product Type Footprint
3.6.3 Isovaleric Acidemia Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Isovaleric Acidemia Treatment Production Value Comparison
4.1.1 United States VS China: Isovaleric Acidemia Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Isovaleric Acidemia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Isovaleric Acidemia Treatment Production Comparison
4.2.1 United States VS China: Isovaleric Acidemia Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Isovaleric Acidemia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Isovaleric Acidemia Treatment Consumption Comparison
4.3.1 United States VS China: Isovaleric Acidemia Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Isovaleric Acidemia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Isovaleric Acidemia Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Isovaleric Acidemia Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023)
4.5 China Based Isovaleric Acidemia Treatment Manufacturers and Market Share
4.5.1 China Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Isovaleric Acidemia Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023)
4.6 Rest of World Based Isovaleric Acidemia Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Isovaleric Acidemia Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 L-Carnitine Supplements
5.2.2 Glycine Supplements
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Isovaleric Acidemia Treatment Production by Type (2018-2029)
5.3.2 World Isovaleric Acidemia Treatment Production Value by Type (2018-2029)
5.3.3 World Isovaleric Acidemia Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Isovaleric Acidemia Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Personal
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Isovaleric Acidemia Treatment Production by Application (2018-2029)
6.3.2 World Isovaleric Acidemia Treatment Production Value by Application (2018-2029)
6.3.3 World Isovaleric Acidemia Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Isovaleric Acidemia Treatment Product and Services
7.1.4 Amgen Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Replimune Group Inc.
7.2.1 Replimune Group Inc. Details
7.2.2 Replimune Group Inc. Major Business
7.2.3 Replimune Group Inc. Isovaleric Acidemia Treatment Product and Services
7.2.4 Replimune Group Inc. Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Replimune Group Inc. Recent Developments/Updates
7.2.6 Replimune Group Inc. Competitive Strengths & Weaknesses
7.3 Transgene SA
7.3.1 Transgene SA Details
7.3.2 Transgene SA Major Business
7.3.3 Transgene SA Isovaleric Acidemia Treatment Product and Services
7.3.4 Transgene SA Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Transgene SA Recent Developments/Updates
7.3.6 Transgene SA Competitive Strengths & Weaknesses
7.4 Oncolys BioPharma
7.4.1 Oncolys BioPharma Details
7.4.2 Oncolys BioPharma Major Business
7.4.3 Oncolys BioPharma Isovaleric Acidemia Treatment Product and Services
7.4.4 Oncolys BioPharma Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Oncolys BioPharma Recent Developments/Updates
7.4.6 Oncolys BioPharma Competitive Strengths & Weaknesses
7.5 Targovax
7.5.1 Targovax Details
7.5.2 Targovax Major Business
7.5.3 Targovax Isovaleric Acidemia Treatment Product and Services
7.5.4 Targovax Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Targovax Recent Developments/Updates
7.5.6 Targovax Competitive Strengths & Weaknesses
7.6 Lokon Pharma
7.6.1 Lokon Pharma Details
7.6.2 Lokon Pharma Major Business
7.6.3 Lokon Pharma Isovaleric Acidemia Treatment Product and Services
7.6.4 Lokon Pharma Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lokon Pharma Recent Developments/Updates
7.6.6 Lokon Pharma Competitive Strengths & Weaknesses
7.7 Vyriad
7.7.1 Vyriad Details
7.7.2 Vyriad Major Business
7.7.3 Vyriad Isovaleric Acidemia Treatment Product and Services
7.7.4 Vyriad Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Vyriad Recent Developments/Updates
7.7.6 Vyriad Competitive Strengths & Weaknesses
7.8 TILT Biotherapeutics
7.8.1 TILT Biotherapeutics Details
7.8.2 TILT Biotherapeutics Major Business
7.8.3 TILT Biotherapeutics Isovaleric Acidemia Treatment Product and Services
7.8.4 TILT Biotherapeutics Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 TILT Biotherapeutics Recent Developments/Updates
7.8.6 TILT Biotherapeutics Competitive Strengths & Weaknesses
7.9 VCNBiosciences
7.9.1 VCNBiosciences Details
7.9.2 VCNBiosciences Major Business
7.9.3 VCNBiosciences Isovaleric Acidemia Treatment Product and Services
7.9.4 VCNBiosciences Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 VCNBiosciences Recent Developments/Updates
7.9.6 VCNBiosciences Competitive Strengths & Weaknesses
7.10 DNAtrix
7.10.1 DNAtrix Details
7.10.2 DNAtrix Major Business
7.10.3 DNAtrix Isovaleric Acidemia Treatment Product and Services
7.10.4 DNAtrix Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 DNAtrix Recent Developments/Updates
7.10.6 DNAtrix Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Isovaleric Acidemia Treatment Industry Chain
8.2 Isovaleric Acidemia Treatment Upstream Analysis
8.2.1 Isovaleric Acidemia Treatment Core Raw Materials
8.2.2 Main Manufacturers of Isovaleric Acidemia Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Isovaleric Acidemia Treatment Production Mode
8.6 Isovaleric Acidemia Treatment Procurement Model
8.7 Isovaleric Acidemia Treatment Industry Sales Model and Sales Channels
8.7.1 Isovaleric Acidemia Treatment Sales Model
8.7.2 Isovaleric Acidemia Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Isovaleric Acidemia Treatment Introduction
1.2 World Isovaleric Acidemia Treatment Supply & Forecast
1.2.1 World Isovaleric Acidemia Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Isovaleric Acidemia Treatment Production (2018-2029)
1.2.3 World Isovaleric Acidemia Treatment Pricing Trends (2018-2029)
1.3 World Isovaleric Acidemia Treatment Production by Region (Based on Production Site)
1.3.1 World Isovaleric Acidemia Treatment Production Value by Region (2018-2029)
1.3.2 World Isovaleric Acidemia Treatment Production by Region (2018-2029)
1.3.3 World Isovaleric Acidemia Treatment Average Price by Region (2018-2029)
1.3.4 North America Isovaleric Acidemia Treatment Production (2018-2029)
1.3.5 Europe Isovaleric Acidemia Treatment Production (2018-2029)
1.3.6 China Isovaleric Acidemia Treatment Production (2018-2029)
1.3.7 Japan Isovaleric Acidemia Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Isovaleric Acidemia Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Isovaleric Acidemia Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Isovaleric Acidemia Treatment Demand (2018-2029)
2.2 World Isovaleric Acidemia Treatment Consumption by Region
2.2.1 World Isovaleric Acidemia Treatment Consumption by Region (2018-2023)
2.2.2 World Isovaleric Acidemia Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Isovaleric Acidemia Treatment Consumption (2018-2029)
2.4 China Isovaleric Acidemia Treatment Consumption (2018-2029)
2.5 Europe Isovaleric Acidemia Treatment Consumption (2018-2029)
2.6 Japan Isovaleric Acidemia Treatment Consumption (2018-2029)
2.7 South Korea Isovaleric Acidemia Treatment Consumption (2018-2029)
2.8 ASEAN Isovaleric Acidemia Treatment Consumption (2018-2029)
2.9 India Isovaleric Acidemia Treatment Consumption (2018-2029)
3 WORLD ISOVALERIC ACIDEMIA TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Isovaleric Acidemia Treatment Production Value by Manufacturer (2018-2023)
3.2 World Isovaleric Acidemia Treatment Production by Manufacturer (2018-2023)
3.3 World Isovaleric Acidemia Treatment Average Price by Manufacturer (2018-2023)
3.4 Isovaleric Acidemia Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Isovaleric Acidemia Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Isovaleric Acidemia Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Isovaleric Acidemia Treatment in 2022
3.6 Isovaleric Acidemia Treatment Market: Overall Company Footprint Analysis
3.6.1 Isovaleric Acidemia Treatment Market: Region Footprint
3.6.2 Isovaleric Acidemia Treatment Market: Company Product Type Footprint
3.6.3 Isovaleric Acidemia Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Isovaleric Acidemia Treatment Production Value Comparison
4.1.1 United States VS China: Isovaleric Acidemia Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Isovaleric Acidemia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Isovaleric Acidemia Treatment Production Comparison
4.2.1 United States VS China: Isovaleric Acidemia Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Isovaleric Acidemia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Isovaleric Acidemia Treatment Consumption Comparison
4.3.1 United States VS China: Isovaleric Acidemia Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Isovaleric Acidemia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Isovaleric Acidemia Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Isovaleric Acidemia Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023)
4.5 China Based Isovaleric Acidemia Treatment Manufacturers and Market Share
4.5.1 China Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Isovaleric Acidemia Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023)
4.6 Rest of World Based Isovaleric Acidemia Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Isovaleric Acidemia Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 L-Carnitine Supplements
5.2.2 Glycine Supplements
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Isovaleric Acidemia Treatment Production by Type (2018-2029)
5.3.2 World Isovaleric Acidemia Treatment Production Value by Type (2018-2029)
5.3.3 World Isovaleric Acidemia Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Isovaleric Acidemia Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Personal
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Isovaleric Acidemia Treatment Production by Application (2018-2029)
6.3.2 World Isovaleric Acidemia Treatment Production Value by Application (2018-2029)
6.3.3 World Isovaleric Acidemia Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Isovaleric Acidemia Treatment Product and Services
7.1.4 Amgen Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Replimune Group Inc.
7.2.1 Replimune Group Inc. Details
7.2.2 Replimune Group Inc. Major Business
7.2.3 Replimune Group Inc. Isovaleric Acidemia Treatment Product and Services
7.2.4 Replimune Group Inc. Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Replimune Group Inc. Recent Developments/Updates
7.2.6 Replimune Group Inc. Competitive Strengths & Weaknesses
7.3 Transgene SA
7.3.1 Transgene SA Details
7.3.2 Transgene SA Major Business
7.3.3 Transgene SA Isovaleric Acidemia Treatment Product and Services
7.3.4 Transgene SA Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Transgene SA Recent Developments/Updates
7.3.6 Transgene SA Competitive Strengths & Weaknesses
7.4 Oncolys BioPharma
7.4.1 Oncolys BioPharma Details
7.4.2 Oncolys BioPharma Major Business
7.4.3 Oncolys BioPharma Isovaleric Acidemia Treatment Product and Services
7.4.4 Oncolys BioPharma Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Oncolys BioPharma Recent Developments/Updates
7.4.6 Oncolys BioPharma Competitive Strengths & Weaknesses
7.5 Targovax
7.5.1 Targovax Details
7.5.2 Targovax Major Business
7.5.3 Targovax Isovaleric Acidemia Treatment Product and Services
7.5.4 Targovax Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Targovax Recent Developments/Updates
7.5.6 Targovax Competitive Strengths & Weaknesses
7.6 Lokon Pharma
7.6.1 Lokon Pharma Details
7.6.2 Lokon Pharma Major Business
7.6.3 Lokon Pharma Isovaleric Acidemia Treatment Product and Services
7.6.4 Lokon Pharma Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lokon Pharma Recent Developments/Updates
7.6.6 Lokon Pharma Competitive Strengths & Weaknesses
7.7 Vyriad
7.7.1 Vyriad Details
7.7.2 Vyriad Major Business
7.7.3 Vyriad Isovaleric Acidemia Treatment Product and Services
7.7.4 Vyriad Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Vyriad Recent Developments/Updates
7.7.6 Vyriad Competitive Strengths & Weaknesses
7.8 TILT Biotherapeutics
7.8.1 TILT Biotherapeutics Details
7.8.2 TILT Biotherapeutics Major Business
7.8.3 TILT Biotherapeutics Isovaleric Acidemia Treatment Product and Services
7.8.4 TILT Biotherapeutics Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 TILT Biotherapeutics Recent Developments/Updates
7.8.6 TILT Biotherapeutics Competitive Strengths & Weaknesses
7.9 VCNBiosciences
7.9.1 VCNBiosciences Details
7.9.2 VCNBiosciences Major Business
7.9.3 VCNBiosciences Isovaleric Acidemia Treatment Product and Services
7.9.4 VCNBiosciences Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 VCNBiosciences Recent Developments/Updates
7.9.6 VCNBiosciences Competitive Strengths & Weaknesses
7.10 DNAtrix
7.10.1 DNAtrix Details
7.10.2 DNAtrix Major Business
7.10.3 DNAtrix Isovaleric Acidemia Treatment Product and Services
7.10.4 DNAtrix Isovaleric Acidemia Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 DNAtrix Recent Developments/Updates
7.10.6 DNAtrix Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Isovaleric Acidemia Treatment Industry Chain
8.2 Isovaleric Acidemia Treatment Upstream Analysis
8.2.1 Isovaleric Acidemia Treatment Core Raw Materials
8.2.2 Main Manufacturers of Isovaleric Acidemia Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Isovaleric Acidemia Treatment Production Mode
8.6 Isovaleric Acidemia Treatment Procurement Model
8.7 Isovaleric Acidemia Treatment Industry Sales Model and Sales Channels
8.7.1 Isovaleric Acidemia Treatment Sales Model
8.7.2 Isovaleric Acidemia Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Isovaleric Acidemia Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Isovaleric Acidemia Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Isovaleric Acidemia Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Isovaleric Acidemia Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Isovaleric Acidemia Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Isovaleric Acidemia Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Isovaleric Acidemia Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Isovaleric Acidemia Treatment Production Market Share by Region (2018-2023)
Table 9. World Isovaleric Acidemia Treatment Production Market Share by Region (2024-2029)
Table 10. World Isovaleric Acidemia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Isovaleric Acidemia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Isovaleric Acidemia Treatment Major Market Trends
Table 13. World Isovaleric Acidemia Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Isovaleric Acidemia Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Isovaleric Acidemia Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Isovaleric Acidemia Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Isovaleric Acidemia Treatment Producers in 2022
Table 18. World Isovaleric Acidemia Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Isovaleric Acidemia Treatment Producers in 2022
Table 20. World Isovaleric Acidemia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Isovaleric Acidemia Treatment Company Evaluation Quadrant
Table 22. World Isovaleric Acidemia Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Isovaleric Acidemia Treatment Production Site of Key Manufacturer
Table 24. Isovaleric Acidemia Treatment Market: Company Product Type Footprint
Table 25. Isovaleric Acidemia Treatment Market: Company Product Application Footprint
Table 26. Isovaleric Acidemia Treatment Competitive Factors
Table 27. Isovaleric Acidemia Treatment New Entrant and Capacity Expansion Plans
Table 28. Isovaleric Acidemia Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Isovaleric Acidemia Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Isovaleric Acidemia Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Isovaleric Acidemia Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Isovaleric Acidemia Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Isovaleric Acidemia Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Isovaleric Acidemia Treatment Production Market Share (2018-2023)
Table 37. China Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Isovaleric Acidemia Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Isovaleric Acidemia Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Isovaleric Acidemia Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Market Share (2018-2023)
Table 47. World Isovaleric Acidemia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Isovaleric Acidemia Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Isovaleric Acidemia Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Isovaleric Acidemia Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Isovaleric Acidemia Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Isovaleric Acidemia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Isovaleric Acidemia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Isovaleric Acidemia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Isovaleric Acidemia Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Isovaleric Acidemia Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Isovaleric Acidemia Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Isovaleric Acidemia Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Isovaleric Acidemia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Isovaleric Acidemia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Isovaleric Acidemia Treatment Product and Services
Table 64. Amgen Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Replimune Group Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Replimune Group Inc. Major Business
Table 69. Replimune Group Inc. Isovaleric Acidemia Treatment Product and Services
Table 70. Replimune Group Inc. Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Replimune Group Inc. Recent Developments/Updates
Table 72. Replimune Group Inc. Competitive Strengths & Weaknesses
Table 73. Transgene SA Basic Information, Manufacturing Base and Competitors
Table 74. Transgene SA Major Business
Table 75. Transgene SA Isovaleric Acidemia Treatment Product and Services
Table 76. Transgene SA Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Transgene SA Recent Developments/Updates
Table 78. Transgene SA Competitive Strengths & Weaknesses
Table 79. Oncolys BioPharma Basic Information, Manufacturing Base and Competitors
Table 80. Oncolys BioPharma Major Business
Table 81. Oncolys BioPharma Isovaleric Acidemia Treatment Product and Services
Table 82. Oncolys BioPharma Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Oncolys BioPharma Recent Developments/Updates
Table 84. Oncolys BioPharma Competitive Strengths & Weaknesses
Table 85. Targovax Basic Information, Manufacturing Base and Competitors
Table 86. Targovax Major Business
Table 87. Targovax Isovaleric Acidemia Treatment Product and Services
Table 88. Targovax Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Targovax Recent Developments/Updates
Table 90. Targovax Competitive Strengths & Weaknesses
Table 91. Lokon Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Lokon Pharma Major Business
Table 93. Lokon Pharma Isovaleric Acidemia Treatment Product and Services
Table 94. Lokon Pharma Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lokon Pharma Recent Developments/Updates
Table 96. Lokon Pharma Competitive Strengths & Weaknesses
Table 97. Vyriad Basic Information, Manufacturing Base and Competitors
Table 98. Vyriad Major Business
Table 99. Vyriad Isovaleric Acidemia Treatment Product and Services
Table 100. Vyriad Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Vyriad Recent Developments/Updates
Table 102. Vyriad Competitive Strengths & Weaknesses
Table 103. TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 104. TILT Biotherapeutics Major Business
Table 105. TILT Biotherapeutics Isovaleric Acidemia Treatment Product and Services
Table 106. TILT Biotherapeutics Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. TILT Biotherapeutics Recent Developments/Updates
Table 108. TILT Biotherapeutics Competitive Strengths & Weaknesses
Table 109. VCNBiosciences Basic Information, Manufacturing Base and Competitors
Table 110. VCNBiosciences Major Business
Table 111. VCNBiosciences Isovaleric Acidemia Treatment Product and Services
Table 112. VCNBiosciences Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. VCNBiosciences Recent Developments/Updates
Table 114. DNAtrix Basic Information, Manufacturing Base and Competitors
Table 115. DNAtrix Major Business
Table 116. DNAtrix Isovaleric Acidemia Treatment Product and Services
Table 117. DNAtrix Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Isovaleric Acidemia Treatment Upstream (Raw Materials)
Table 119. Isovaleric Acidemia Treatment Typical Customers
Table 120. Isovaleric Acidemia Treatment Typical Distributors
Table 1. World Isovaleric Acidemia Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Isovaleric Acidemia Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Isovaleric Acidemia Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Isovaleric Acidemia Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Isovaleric Acidemia Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Isovaleric Acidemia Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Isovaleric Acidemia Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Isovaleric Acidemia Treatment Production Market Share by Region (2018-2023)
Table 9. World Isovaleric Acidemia Treatment Production Market Share by Region (2024-2029)
Table 10. World Isovaleric Acidemia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Isovaleric Acidemia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Isovaleric Acidemia Treatment Major Market Trends
Table 13. World Isovaleric Acidemia Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Isovaleric Acidemia Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Isovaleric Acidemia Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Isovaleric Acidemia Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Isovaleric Acidemia Treatment Producers in 2022
Table 18. World Isovaleric Acidemia Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Isovaleric Acidemia Treatment Producers in 2022
Table 20. World Isovaleric Acidemia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Isovaleric Acidemia Treatment Company Evaluation Quadrant
Table 22. World Isovaleric Acidemia Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Isovaleric Acidemia Treatment Production Site of Key Manufacturer
Table 24. Isovaleric Acidemia Treatment Market: Company Product Type Footprint
Table 25. Isovaleric Acidemia Treatment Market: Company Product Application Footprint
Table 26. Isovaleric Acidemia Treatment Competitive Factors
Table 27. Isovaleric Acidemia Treatment New Entrant and Capacity Expansion Plans
Table 28. Isovaleric Acidemia Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Isovaleric Acidemia Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Isovaleric Acidemia Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Isovaleric Acidemia Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Isovaleric Acidemia Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Isovaleric Acidemia Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Isovaleric Acidemia Treatment Production Market Share (2018-2023)
Table 37. China Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Isovaleric Acidemia Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Isovaleric Acidemia Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Isovaleric Acidemia Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Isovaleric Acidemia Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Market Share (2018-2023)
Table 47. World Isovaleric Acidemia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Isovaleric Acidemia Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Isovaleric Acidemia Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Isovaleric Acidemia Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Isovaleric Acidemia Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Isovaleric Acidemia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Isovaleric Acidemia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Isovaleric Acidemia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Isovaleric Acidemia Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Isovaleric Acidemia Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Isovaleric Acidemia Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Isovaleric Acidemia Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Isovaleric Acidemia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Isovaleric Acidemia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Isovaleric Acidemia Treatment Product and Services
Table 64. Amgen Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Replimune Group Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Replimune Group Inc. Major Business
Table 69. Replimune Group Inc. Isovaleric Acidemia Treatment Product and Services
Table 70. Replimune Group Inc. Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Replimune Group Inc. Recent Developments/Updates
Table 72. Replimune Group Inc. Competitive Strengths & Weaknesses
Table 73. Transgene SA Basic Information, Manufacturing Base and Competitors
Table 74. Transgene SA Major Business
Table 75. Transgene SA Isovaleric Acidemia Treatment Product and Services
Table 76. Transgene SA Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Transgene SA Recent Developments/Updates
Table 78. Transgene SA Competitive Strengths & Weaknesses
Table 79. Oncolys BioPharma Basic Information, Manufacturing Base and Competitors
Table 80. Oncolys BioPharma Major Business
Table 81. Oncolys BioPharma Isovaleric Acidemia Treatment Product and Services
Table 82. Oncolys BioPharma Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Oncolys BioPharma Recent Developments/Updates
Table 84. Oncolys BioPharma Competitive Strengths & Weaknesses
Table 85. Targovax Basic Information, Manufacturing Base and Competitors
Table 86. Targovax Major Business
Table 87. Targovax Isovaleric Acidemia Treatment Product and Services
Table 88. Targovax Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Targovax Recent Developments/Updates
Table 90. Targovax Competitive Strengths & Weaknesses
Table 91. Lokon Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Lokon Pharma Major Business
Table 93. Lokon Pharma Isovaleric Acidemia Treatment Product and Services
Table 94. Lokon Pharma Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lokon Pharma Recent Developments/Updates
Table 96. Lokon Pharma Competitive Strengths & Weaknesses
Table 97. Vyriad Basic Information, Manufacturing Base and Competitors
Table 98. Vyriad Major Business
Table 99. Vyriad Isovaleric Acidemia Treatment Product and Services
Table 100. Vyriad Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Vyriad Recent Developments/Updates
Table 102. Vyriad Competitive Strengths & Weaknesses
Table 103. TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 104. TILT Biotherapeutics Major Business
Table 105. TILT Biotherapeutics Isovaleric Acidemia Treatment Product and Services
Table 106. TILT Biotherapeutics Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. TILT Biotherapeutics Recent Developments/Updates
Table 108. TILT Biotherapeutics Competitive Strengths & Weaknesses
Table 109. VCNBiosciences Basic Information, Manufacturing Base and Competitors
Table 110. VCNBiosciences Major Business
Table 111. VCNBiosciences Isovaleric Acidemia Treatment Product and Services
Table 112. VCNBiosciences Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. VCNBiosciences Recent Developments/Updates
Table 114. DNAtrix Basic Information, Manufacturing Base and Competitors
Table 115. DNAtrix Major Business
Table 116. DNAtrix Isovaleric Acidemia Treatment Product and Services
Table 117. DNAtrix Isovaleric Acidemia Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Isovaleric Acidemia Treatment Upstream (Raw Materials)
Table 119. Isovaleric Acidemia Treatment Typical Customers
Table 120. Isovaleric Acidemia Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Isovaleric Acidemia Treatment Picture
Figure 2. World Isovaleric Acidemia Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Isovaleric Acidemia Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 5. World Isovaleric Acidemia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Isovaleric Acidemia Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Isovaleric Acidemia Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 10. China Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 12. Isovaleric Acidemia Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Isovaleric Acidemia Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Isovaleric Acidemia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Isovaleric Acidemia Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Isovaleric Acidemia Treatment Markets in 2022
Figure 26. United States VS China: Isovaleric Acidemia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Isovaleric Acidemia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Isovaleric Acidemia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Isovaleric Acidemia Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Isovaleric Acidemia Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Market Share 2022
Figure 32. World Isovaleric Acidemia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Isovaleric Acidemia Treatment Production Value Market Share by Type in 2022
Figure 34. L-Carnitine Supplements
Figure 35. Glycine Supplements
Figure 36. Others
Figure 37. World Isovaleric Acidemia Treatment Production Market Share by Type (2018-2029)
Figure 38. World Isovaleric Acidemia Treatment Production Value Market Share by Type (2018-2029)
Figure 39. World Isovaleric Acidemia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Isovaleric Acidemia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Isovaleric Acidemia Treatment Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Personal
Figure 44. Other
Figure 45. World Isovaleric Acidemia Treatment Production Market Share by Application (2018-2029)
Figure 46. World Isovaleric Acidemia Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Isovaleric Acidemia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Isovaleric Acidemia Treatment Industry Chain
Figure 49. Isovaleric Acidemia Treatment Procurement Model
Figure 50. Isovaleric Acidemia Treatment Sales Model
Figure 51. Isovaleric Acidemia Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Isovaleric Acidemia Treatment Picture
Figure 2. World Isovaleric Acidemia Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Isovaleric Acidemia Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 5. World Isovaleric Acidemia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Isovaleric Acidemia Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Isovaleric Acidemia Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 10. China Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Isovaleric Acidemia Treatment Production (2018-2029) & (K Units)
Figure 12. Isovaleric Acidemia Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Isovaleric Acidemia Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Isovaleric Acidemia Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Isovaleric Acidemia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Isovaleric Acidemia Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Isovaleric Acidemia Treatment Markets in 2022
Figure 26. United States VS China: Isovaleric Acidemia Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Isovaleric Acidemia Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Isovaleric Acidemia Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Isovaleric Acidemia Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Isovaleric Acidemia Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Isovaleric Acidemia Treatment Production Market Share 2022
Figure 32. World Isovaleric Acidemia Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Isovaleric Acidemia Treatment Production Value Market Share by Type in 2022
Figure 34. L-Carnitine Supplements
Figure 35. Glycine Supplements
Figure 36. Others
Figure 37. World Isovaleric Acidemia Treatment Production Market Share by Type (2018-2029)
Figure 38. World Isovaleric Acidemia Treatment Production Value Market Share by Type (2018-2029)
Figure 39. World Isovaleric Acidemia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Isovaleric Acidemia Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Isovaleric Acidemia Treatment Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Personal
Figure 44. Other
Figure 45. World Isovaleric Acidemia Treatment Production Market Share by Application (2018-2029)
Figure 46. World Isovaleric Acidemia Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Isovaleric Acidemia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Isovaleric Acidemia Treatment Industry Chain
Figure 49. Isovaleric Acidemia Treatment Procurement Model
Figure 50. Isovaleric Acidemia Treatment Sales Model
Figure 51. Isovaleric Acidemia Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
